Mayo Clinic | Strategic Alliance Partners

Latest from Mayo Clinic


Experts Review Pirtobrutinib Clinical Data and Share its Utilization in Practice

August 15, 2024

A medical expert offers commentary on the recent FDA accelerated approval of pirtobrutinib, discussing the implications of the BRUIN trial findings that supported this decision for chronic lymphocytic leukemia treatment.